carbamates has been researched along with darapladib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahnson, BJ; Brown, SJ; Cravatt, BF; Ferguson, J; Fernandez-Vega, V; Gonzalez, TD; Hodder, P; Hsu, KL; Nagano, JM; Niphakis, MJ; Rosen, H; Speers, AE; Spicer, T; Srinivasan, P; Whitby, LR | 1 |
| Johnston, CW; Khyzha, N; Magarvey, NA; Zvanych, R | 1 |
2 other study(ies) available for carbamates and darapladib
| Article | Year |
|---|---|
Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Benzaldehydes; Carbamates; Cell Line, Tumor; Enzyme Inhibitors; Humans; Mice; Molecular Structure; Oximes; Piperazines; Quinolines | 2013 |
Nonribosomal assembly of natural lipocyclocarbamate lipoprotein-associated phospholipase inhibitors.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Atherosclerosis; Benzaldehydes; Biological Products; Carbamates; Enzyme Inhibitors; Models, Molecular; Oximes; Peptide Synthases; Pseudomonas fluorescens | 2013 |